[ad_1]
bioMérieux, a global leader in in vitro diagnostics, has received Health Canada approval for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel, a rapid diagnosis tool that presents a significant development in the respiratory and throat infection category.
This innovative multiplex PCR test can identify nucleic acids from up to 15 common bacteria, viruses, and viral subtypes in approximately 15 minutes. The panel uses samples from nasopharyngeal or throat swabs. Designed for point-of-care use, the advanced rapid diagnosis tool is accessible to non-lab professionals and can be used in settings such as emergency rooms, intensive care units, and remote healthcare centers with limited laboratory resources.
bioMérieux also integrates its panel with the BIOFIRE® FIREWORKS® data management portal. This detail enhances the tool’s utility by providing comprehensive analytics and pathogen surveillance.
Image Credit: bioMérieux
[ad_2]
Source link